QCG
RMD icon

Quadrant Capital Group’s ResMed RMD Stock Holding History

Quadrant Capital Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
6,233
-20
-0.3% -$4.14K 0.03% 506
2026
Q1 		$1.4M Sell
6,253
-248
-4% -$61.8K 0.04% 418
2025
Q4 		$1.57M Buy
6,501
+4
+0.1% +$1.02K 0.05% 343
2025
Q3 		$1.78M Buy
6,497
+70
+1% +$19.1K 0.06% 285
2025
Q2 		$1.66M Buy
6,427
+154
+2% +$36.7K 0.06% 278
2025
Q1 		$1.4M Buy
6,273
+4,443
+243% +$1.04M 0.05% 280
2024
Q4 		$419K Sell
1,830
-81
-4% -$19.5K 0.03% 391
2024
Q3 		$467K Buy
1,911
+26
+1% +$5.81K 0.03% 362
2024
Q2 		$361K Buy
1,885
+44
+2% +$8.93K 0.03% 430
2024
Q1 		$365K Buy
1,841
+120
+7% +$22K 0.03% 406
2023
Q4 		$296K Buy
1,721
+35
+2% +$5.38K 0.03% 450
2023
Q3 		$249K Buy
1,686
+472
+39% +$85.3K 0.03% 445
2023
Q2 		$265K Sell
1,214
-155
-11% -$34.5K 0.03% 419
2023
Q1 		$300K Sell
1,369
-77
-5% -$16.7K 0.03% 394
2022
Q4 		$301K Sell
1,446
-95
-6% -$20.9K 0.03% 365
2022
Q3 		$336K Buy
1,541
+181
+13% +$41.2K 0.04% 292
2022
Q2 		$285K Buy
1,360
+307
+29% +$65.4K 0.04% 332
2022
Q1 		$256K Buy
1,053
+4
+0.4% +$968 0.03% 385
2021
Q4 		$273K Sell
1,049
-81
-7% -$21K 0.03% 358
2021
Q3 		$298K Buy
1,130
+42
+4% +$11.5K 0.04% 292
2021
Q2 		$268K Buy
1,088
+10
+0.9% +$2.1K 0.04% 306
2021
Q1 		$209K Buy
1,078
+55
+5% +$11K 0.03% 342
2020
Q4 		$217K Buy
1,023
+164
+19% +$32.7K 0.04% 286
2020
Q3 		$147K Buy
859
+9
+1% +$1.66K 0.03% 330
2020
Q2 		$163K Sell
850
-742
-47% -$121K 0.04% 313
2020
Q1 		$234K Buy
1,592
+91
+6% +$14.5K 0.04% 353
2019
Q4 		$223K Buy
1,501
+24
+2% +$3.46K 0.03% 622
2019
Q3 		$195K Sell
1,477
-105
-7% -$13.8K 0.03% 610
2019
Q2 		$188K Buy
1,582
+25
+2% +$2.77K 0.03% 593
2019
Q1 		$157K Buy
1,557
+658
+73% +$67.9K 0.03% 590
2018
Q4 		$97K Hold
899
– – 0.03% 619
2018
Q3 		$97K Hold
899
– – 0.03% 421
2018
Q2 		$89K Hold
899
– – 0.03% 450
2018
Q1 		$83K Sell
899
-3
-0.3% -$283 0.03% 478
2017
Q4 		$70K Hold
902
– – 0.03% 508
2017
Q3 		$62K Buy
902
+3
+0.3% +$229 0.03% 540
2017
Q2 		$62K Sell
899
-128
-12% -$9.16K 0.03% 482
2017
Q1 		$72K Buy
1,027
+64
+7% +$4.42K 0.03% 437
2016
Q4 		$58K Sell
963
-4
-0.4% -$245 0.03% 390
2016
Q3 		$61K Hold
967
– – 0.04% 372
2016
Q2 		$59K Buy
967
+47
+5% +$2.77K 0.04% 354
2016
Q1 		$52K Buy
920
+20
+2% +$1.13K 0.03% 378
2015
Q4 		$48K Hold
900
– – 0.03% 391
2015
Q3 		$45K Hold
900
– – 0.03% 432
2015
Q2 		$50K Buy
+900
New +$56.8K 0.03% 433

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Quadrant Capital Group's RMD Position: Q2 2026 in Review

Quadrant Capital Group reduced its ResMed (RMD) stake by 0.32% in Q2 2026, selling an estimated $4.14K and leaving 6,233 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #506.

Quadrant Capital Group first reported a position in RMD in Q2 2015 and has held it in 45 quarters since. The position peaked at $1.78M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Quadrant Capital Group held 6,233 shares of ResMed worth $1.21M as of Q2 2026.
  • Quadrant Capital Group sold 20 ResMed shares in Q2 2026, an estimated $4.14K.
  • ResMed made up 0.03% of Quadrant Capital Group's portfolio in Q2 2026, its #506 holding.
  • Quadrant Capital Group first reported a position in ResMed in Q2 2015 and has held it in 45 quarters since.
  • Quadrant Capital Group's ResMed position peaked at $1.78M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.